Single-Use Down Scale Downstream Processing for Validation of Viral Safety Measures
Posted on August 16, 2021
Author Prof. Dr. Rolf G. Werner, Corporate Senior Vice President,
Boehringer Ingelheim
Introduction Mammalian cell cultures, since the development of the first biopharmaceutical, tissue plasminogen activator expressed in Chinese Hamster Ovary cells (CHO) for acute myocardial infarction and stroke, have become a unique tool to produce in large cGMP scale of 15.000 – 20.000L fully aut...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















